Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Container Corporation Of India Ltd, Poly Medicure Ltd, Aarti Pharmalabs Ltd and Le Travenues Technology Ltd are among the other losers in the BSE's 'A' group today, 26 May 2026.
Techno Electric & Engineering Company Ltd lost 12.48% to Rs 1199.55 at 14:46 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 82027 shares were traded on the counter so far as against the average daily volumes of 22651 shares in the past one month.
Container Corporation Of India Ltd crashed 7.28% to Rs 475. The stock was the second biggest loser in 'A' group.On the BSE, 4.74 lakh shares were traded on the counter so far as against the average daily volumes of 85919 shares in the past one month.
Poly Medicure Ltd tumbled 6.56% to Rs 1437.5. The stock was the third biggest loser in 'A' group.On the BSE, 15567 shares were traded on the counter so far as against the average daily volumes of 9662 shares in the past one month.
Aarti Pharmalabs Ltd dropped 5.30% to Rs 694.65. The stock was the fourth biggest loser in 'A' group.On the BSE, 18435 shares were traded on the counter so far as against the average daily volumes of 9891 shares in the past one month.
Le Travenues Technology Ltd shed 4.99% to Rs 168.4. The stock was the fifth biggest loser in 'A' group.On the BSE, 11.38 lakh shares were traded on the counter so far as against the average daily volumes of 69961 shares in the past one month.
For the full year,net profit declined 4.85% to Rs 322.14 crore in the year ended March 2026 as against Rs 338.56 crore during the previous year ended March 2025. Sales rose 12.30% to Rs 1875.26 crore in the year ended March 2026 as against Rs 1669.83 crore during the previous year ended March 2025.
Operating EBITDA dropped 8% to Rs 112.1 crore in Q4 FY26 from Rs 121.9 crore posted in Q4 FY25. EBITDA margin contracted to 667 bps to 21% in Q4 FY26 as against 27.6% in Q4 FY25.
Revenue from infusion therapy segment rose 1.9% YoY to Rs 256.1 crore while revenue from renal segment climbed 21.3% YoY to Rs 56.2 crore and revenue from others segment stood at Rs 222.1 crore, up 55.2% YoY.
On full year basis, the company’s consolidated net profit fell 4.85% to Rs 322.13 crore on 12.3% increase in revenue from operations to Rs 1,875.25 crore in FY26 over FY25.
Meanwhile, the company’s board recommended a dividend of Rs 3.5 per equity shares of Rs 5 each for the financial year 2025-26.
Poly Medicure exports plastic medical disposables/surgical devices. It manufactures and supplies approximately 100 types of disposable medical devices in the product verticals of infusion therapy, anesthesia, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis and central venous access catheters.